Clinical Newsletter

Clinical Newsletter

Regular updates on our latest clinical studies.

Subscribe

Búsqueda de publicación

Nuestros equipos de investigación y desarrollo operan a nivel global y generan sinergias desde nuestra experiencia colectiva y a partir de disciplinas relacionadas. Del mismo modo estamos intercambiando información constantemente a nivel internacional con instituciones técnicas independientes, importantes líderes y multiplicadores de opinión para poder garantizar una gestión de la cooperación y del conocimiento al más alto nivel. Como parte de este proceso, también llevamos a cabo una investigación exhaustiva, cuyos resultados presentamos continuamente en workshops, conferencias y simposios - tanto en forma de documentación gratuita, como en ponencias ofrecidas por nuestros socios cooperadores - así como publicaciones en prensa científica de renombre. Esta base de datos contiene un largo número de estos artículos basados en evidencias científicas, cuya mayoría ha sido evaluada por asesores independientes:

  1. Poster

    Management of foot wounds resulting frrom Cutaneous T-cell lymphoma using an innovative anatomically shaped silicone foam dressing

    Poster presented at Wounds UK 2024 06.11.2023 Harrogate, UK
  2. Poster

    Antibiofilm performance of silver nanoparticles and new silver nanoparticle wound dressing

    Poster presented at SAWC Spring 2023 26.04.2023 National Harbor, United States

    Introduction:

    A new, non-silver cellulose-based wound dressing has demonstrated to be effective against biofilms and preventing bacterial penetration. The fibres of the new dressing are coated with a novel antibiofilm formulation containing PHMB (polyhexanide).

    Methods:

    The biofilm method used in the study was based on a gauze model developed by Bowler and Parsons, 2016. 1 In the first step, circular pieces of 1.6 cm sterile gauze were punched out before being transferred into sterile 100 ml Erlenmeyer flasks and submerged in 25 ml of liquid bacterial culture containing either S.aureus or P.aeruginosa at approximately 1-5 x 105 CFU/ ml. The Erlenmeyer flasks were subsequently shaken for 48h in order to coat the gauze with a mature biofilm.

    Each piece of gauze was then placed onto an individual agar plate and covered with a 3.2 cm disk of the test dressing and wetted with 1.5 ml of simulated wound fluid. Finally, the test dressings were covered with a piece of silicon dressing and the plate closed with parafilm.

    Bacterial penetration testing was performed by saturating 4.2 x 4.2 cm dressing samples with aliquots of SWF. Dressings were subsequently incubated (pre-conditioned) at 37°C for 6-days. After this period, the cut samples were placed onto fresh agar plates and inoculated with bacterial suspension containing 1x 108 CFU/ml evenly around the edge of the dressing. Petri dishes were then incubated for 24h, the dressings removed and plates inspected for growth.

    Results:

    The new, non-silver wound dressings completely killed all the bacteria in the both the S. aureus and P.aeruginosa biofilms. In comparison, a silver based competitor dressing did not remove the biofilm for either bacteria.

    Bacterial penetration was also prevented in the new dressing.

    Discussion:

    Initial evidence would suggest the new non-silver dressing is highly effective against biofilms and preventing bacterial penetration.

  3. Poster

    The outcomes of a new reusable fibreglass and polyester combined total contact cast system (Cellacast Lohmann and Rauscher) in the management of plantar ulcers

    Poster presented at EWMA 2023 03.05.2023 Milan, Italy
  4. Poster

    A Combination of Both a Tissue Viability Nurse's and Patients' Experiences of a Wound Debridement Product

    Poster presented at Wounds UK 2024 06.11.2023 Harrogate, UK
  5. Poster

    Surgical treatment of extended keloid scar with dermal substitute, negative pressure wound therapy and partial thickness skin graft: A case study

    Poster presented at WUWHS 2022 01.03.2022 Abu Dhabi, UAE
    Further versions
  6. Poster

    THE USE OF NIGHT TIME GARMENTS FOR CHRONIC EDEMA MANAGEMENT IMPACTS PATIENTS' QUALITY OF LIFE AND EDEMA MANAGEMENT

    Poster presented at WUWHS 2022 01.03.2022 Abu Dhabi, UAE
    Further versions
  7. Poster

    REDUCED TISSUE FIBROSIS WITH ADDITION OF TEXTURED COMPRESSION GARMENTS TO EDEMA MANAGEMENT PROGRAM

    Poster presented at WUWHS 2022 01.03.2022 Abu Dhabi, UAE
    Downloads Citation (RIS)
    Further versions
  8. Poster

    Rapid wound debridement: Clinical outcomes and clinician satisfaction after up to 2 applications of monofilament fibre debridement technology*

    Poster presented at WUWHS 2022 01.03.2022 Abu Dhabi, UAE
    Products Debrisoft Pad
    Further versions
  9. Poster

    Real-world wound debridement: Clinical outcomes and user satisfaction after biofilm pathway management using monofilament fibredebridement technology* over 2 weeks

    Poster presented at WUWHS 2022 01.03.2022 Abu Dhabi, UAE
    Products Debrisoft Pad
    Further versions
  10. Poster

    Mechanical debridement of leg ulcers and the surrounding skin using a monofilament fibre debridement pad designed for larger wounds and surface areas

    Poster presented at WUWHS 2022 01.03.2022 Abu Dhabi, UAE
    Products Debrisoft Pad

Aviso COFEPRIS 183300202C1039

Este sitio web contiene información sobre productos y prácticas médicas, está dirigido a una amplia audiencia y podría contener datos de productos o información que no son accesibles o válidos en su país. Tenga en cuenta que nosotros no tomamos ninguna responsabilidad por acceder a información que puede que no cumpla con algún requerimiento legal, de regulación, de registro o de uso en su país de origen. Las prácticas y regulaciones médicas pueden diferir de un país a otro.